p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment
出版年份 2013 全文链接
标题
p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment
作者
关键词
-
出版物
Cell Death & Disease
Volume 4, Issue 4, Pages e589-e589
出版商
Springer Nature
发表日期
2013-04-11
DOI
10.1038/cddis.2013.118
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Functional Sphere Profiling Reveals the Complexity of Neuroblastoma Tumor-Initiating Cell Model
- (2015) Aurélie Coulon et al. NEOPLASIA
- CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
- (2012) Hervé Sartelet et al. HISTOPATHOLOGY
- Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells
- (2011) Annalisa Pezzolo et al. CELL RESEARCH
- Biology of Cox-2: An Application in Cancer Therapeutics
- (2011) Zakir Khan et al. CURRENT DRUG TARGETS
- PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage
- (2011) Barbara Marengo et al. PLoS One
- p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity
- (2010) B. Kumar et al. CANCER RESEARCH
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?
- (2010) Yohannes Mebratu et al. CELL CYCLE
- Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion
- (2010) D. Hussein et al. NEURO-ONCOLOGY
- C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells
- (2010) S. Hiratsuka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Post-Translational Regulation of Oct4 Transcriptional Activity
- (2009) Jonathan P. Saxe et al. PLoS One
- Inhibitors Targeting the LFA-1/ICAM-1 Cell-Adhesion Interaction: Design and Mechanism of Action
- (2008) Tahl Zimmerman et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
- (2008) Yu-Chih Chen et al. PLoS One
- Chemokines in neuroectodermal cancers: The crucial growth signal from the soil
- (2008) Nicole Gross et al. SEMINARS IN CANCER BIOLOGY
- Chemokines in neuroectodermal tumour progression and metastasis
- (2008) Lizzia Raffaghello et al. SEMINARS IN CANCER BIOLOGY
- Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma
- (2007) Barbara Marengo et al. FREE RADICAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started